Affymetrix Inc., of Santa Clara, Calif., added Robert Ellis as executive vice president, product development and quality, and Barbara Caulfield as executive vice president and general counsel; promoted Gregory Schiffman to vice president and chief financial officer (Effective Aug. 10); and said Edward Hurwitz will be senior vice president, corporate strategy and new ventures (Aug. 10).

Albany Molecular Research Inc., of Albany, N.Y., elected Shirley Ann Jackson to its board.

Applera Corp., of Norwalk, Conn., appointed Peter Dworkin vice president, investor relations for Applera Corp.; Robert Bennett director, investor relations for Celera Genomics Group; and David Speechly vice president, European corporate and financial communications for Applera Corp.

Atairgin Technologies Inc., of Irvine, Calif., promoted Rob Goshert to vice president of business operations and Kiu Leung to vice president of diagnostics.

Banques Populaires, of Paris, said Isabelle de Cremoux joined its venture capital subsidiary, Spef Venture, as investment director to develop the life science department.

BioImage A/S, of Soeborg, Denmark, appointed Edwin Moses to its board.

Biomoda Inc., of Albuquerque, N.M., added Janet Mercer-Smith to its scientific advisory board.

BioProgress Technology International Inc., of Atlanta, added Carey Bottom to its board.

Cypress Bioscience Inc., of San Diego, formed a psychopharmacology advisory board consisting of: Charles Nemeroff, Martin Keller, Stephen Stahl, Charles Reynolds, David Dunner, Lorrin Koran, Jan Fawcett and Ranga Rama Krishnan.

Demegen Inc., of Pittsburgh, elected Joseph Lovett to its board.

Egea Biosciences Inc., of San Diego, appointed Tod Lauerman senior vice president of business development.

EntreMed Inc., of Rockville, Md., appointed Amy Finan director of corporate communications and investor relations.

Epicyte Pharmaceutical Inc., of San Diego, added Neil Cowen as vice president of strategic development.

Exact Sciences Corp., of Maynard, Mass., added Stephen Read as vice president and controller, David Nikka as vice president of resources and development, and William Pignato as vice president of regulatory affairs.